Demand grows for superfast cycler after LABVOLUTION and ESHG showing
Amsterdam, July, 2017: Dutch biotechnology company Molecular Biology Systems(MBS) today announced it has signed an exclusive distributor agreement for its revolutionary NEXTGENPCR thermal cycler with Isogen Life Sciences. This follows highly successful showings of the first production models at the recent ESHG and LABVOLUTIONS meetings. The distributorship covers both Benelux where Isogen has facilities in De Meern (Netherlands) and Temse (Belgium and Luxembourg) and Spain, which is managed from Barcelona.
